Investment Trusts

Polar Capital Global Healthcare Trust

PCGH:LSE

Polar Capital Global Healthcare Trust

  • Price (GBX)363.00
  • Today's Change0.00 / 0.00%
  • Shares traded246.28k
  • 1 Year change19.80%
  • Beta0.5984
Data delayed at least 20 minutes, as of Nov 21 2024 16:39 GMT.
More ▼
Total returns on £1000
1Y
Fund/benchmarkChange
PricePolar Capital Global Healthcare Trust (Ordinary Share)+19.95%
NAVPolar Capital Global Healthcare Trust (Ordinary Share)+14.36%
Morningstar's BenchmarkMSCI ACWI/Health Care NR GBP enhanced--

Key statistics

On Thursday, Polar Capital Global Healthcare Trust (PCGH:LSE) closed at 363.00, -9.70% below its 52-week high of 402.00, set on Aug 30, 2024.
52-week range
Today
300.84Nov 21 2023402.00Aug 30 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding121.27m
Market cap440.21m GBP
Total assets463.64m GBP
Total expense ratio0.94%
High364.00
Low360.00
Previous close363.00
Average volume361.02k
YTD Change+10.00%
Beta0.5984
Diluted NAV (est)385.79
Diluted NAV (last pub)378.25
Premium/Discount-5.91%
Net Gearing0.00%
Annual div (ADY)2.40 GBX
Annual div yield (ADY)0.66%
Div ex-dateAug 01 2024
Div pay-dateAug 30 2024
Data delayed at least 20 minutes, as of Nov 21 2024 16:39 GMT.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.